Previous research found that Menin is closely associated with glycometabolism and Menin inhibitors induced increase in glycolysis occurs in an mTOR-independent manner, which enhances the sensitivity of colorectal cancer cells to EGFR inhibitors [28]. The gene discussed is MEN1; the disease is colorectal cancer.